Tagrisso combined with chemotherapy improved how long patients with EGFR- and TP53-mutant NSCLC lived without their cancer ...
Committee for Medicinal Products for Human Use (CHMP) adopted positive opinions for two drugs for the treatment of adults ...
SCLC diagnosis involves imaging, biopsies, and lab tests to assess tumor spread and guide treatment decisions. Treatment options vary by stage, with surgery, chemotherapy, radiation, and immunotherapy ...
Chemotherapy-induced myelosuppression (CIM) remains one of the most significant and underappreciated barriers to delivering ...
Pharmacosmos initiates phase III clinical trial of trilaciclib in limited-stage small cell lung cancer MORRISTOWN, NJ, ...
Adding immunotherapy to chemotherapy before surgery for patients with operable non-small cell lung cancer—the leading cause of cancer deaths worldwide—improved long-term survival overall compared with ...
Identification and validation of hypoxia and energy metabolism-related gene signatures in lung adenocarcinoma and their potential implications for immunotherapy. This is an ASCO Meeting Abstract from ...
Digital pathology–based AI spatial biomarker to predict outcomes for immune checkpoint inhibitors in advanced non-small cell lung cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results